{"version":"1.0","type":"link","title":"Durability of Response With Selpercatinib in Patients With -Activated Thyroid Cancer: Long-Term Safety and Efficacy From LIBRETTO-001.","author_name":"Wirth LJ 외","author_url":"https://prs-insight.online/author/Wirth%20LJ","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/142836","thumbnail_width":1200,"thumbnail_height":630}